Annual Net Income
-$67.00 M
-$42.51 M-173.59%
31 December 2023
Summary:
Verrica Pharmaceuticals annual net profit is currently -$67.00 million, with the most recent change of -$42.51 million (-173.59%) on 31 December 2023. During the last 3 years, it has fallen by -$24.30 million (-56.92%). VRCA annual net income is now -3402.09% below its all-time high of -$1.91 million, reached on 31 December 2016.VRCA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$22.86 M
-$5.67 M-33.02%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly net profit is currently -$22.86 million, with the most recent change of -$5.67 million (-33.02%) on 30 September 2024. Over the past year, it has increased by +$1.94 million (+7.83%). VRCA quarterly net income is now -27642.17% below its all-time high of $83.00 thousand, reached on 30 September 2022.VRCA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$84.99 M
+$1.94 M+2.23%
30 September 2024
Summary:
Verrica Pharmaceuticals TTM net profit is currently -$84.99 million, with the most recent change of +$1.94 million (+2.23%) on 30 September 2024. Over the past year, it has dropped by -$36.68 million (-75.92%). VRCA TTM net income is now -14810.70% below its all-time high of -$570.00 thousand, reached on 31 March 2017.VRCA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -173.6% | +7.8% | -75.9% |
| 3 y3 years | -56.9% | -78.2% | -120.7% |
| 5 y5 years | -224.5% | -275.4% | -201.9% |
VRCA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -173.6% | at low | <-9999.0% | +7.8% | -276.0% | +2.2% |
| 5 y | 5 years | -224.5% | at low | <-9999.0% | +7.8% | -276.0% | +2.2% |
| alltime | all time | -3402.1% | at low | <-9999.0% | +7.8% | <-9999.0% | +2.2% |
Verrica Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$22.86 M(+33.0%) | -$84.99 M(-2.2%) |
| June 2024 | - | -$17.19 M(-15.5%) | -$86.93 M(+7.7%) |
| Mar 2024 | - | -$20.33 M(-17.4%) | -$80.74 M(+20.5%) |
| Dec 2023 | -$67.00 M(+173.6%) | -$24.61 M(-0.8%) | -$67.00 M(+38.7%) |
| Sept 2023 | - | -$24.80 M(+125.7%) | -$48.31 M(+106.2%) |
| June 2023 | - | -$10.99 M(+66.8%) | -$23.43 M(+3.6%) |
| Mar 2023 | - | -$6.59 M(+11.1%) | -$22.61 M(-7.7%) |
| Dec 2022 | -$24.49 M(-30.2%) | -$5.93 M(-7247.0%) | -$24.49 M(-12.8%) |
| Sept 2022 | - | $83.00 K(-100.8%) | -$28.09 M(-31.5%) |
| June 2022 | - | -$10.17 M(+20.0%) | -$41.01 M(-3.8%) |
| Mar 2022 | - | -$8.47 M(-11.2%) | -$42.61 M(+21.5%) |
| Dec 2021 | -$35.08 M(-17.8%) | -$9.54 M(-25.6%) | -$35.08 M(-8.9%) |
| Sept 2021 | - | -$12.83 M(+9.0%) | -$38.52 M(+6.5%) |
| June 2021 | - | -$11.78 M(+1158.0%) | -$36.17 M(+7.0%) |
| Mar 2021 | - | -$936.00 K(-92.8%) | -$33.81 M(-20.8%) |
| Dec 2020 | -$42.69 M | -$12.98 M(+23.8%) | -$42.69 M(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$10.49 M(+11.4%) | -$37.35 M(+13.3%) |
| June 2020 | - | -$9.41 M(-4.2%) | -$32.96 M(+7.9%) |
| Mar 2020 | - | -$9.82 M(+28.6%) | -$30.55 M(+8.3%) |
| Dec 2019 | -$28.21 M(+36.6%) | -$7.64 M(+25.4%) | -$28.21 M(+0.2%) |
| Sept 2019 | - | -$6.09 M(-13.0%) | -$28.15 M(+0.7%) |
| June 2019 | - | -$7.00 M(-6.4%) | -$27.96 M(+6.4%) |
| Mar 2019 | - | -$7.48 M(-1.3%) | -$26.28 M(+27.3%) |
| Dec 2018 | -$20.65 M(+363.1%) | -$7.58 M(+28.3%) | -$20.65 M(+42.4%) |
| Sept 2018 | - | -$5.91 M(+11.1%) | -$14.51 M(+45.7%) |
| June 2018 | - | -$5.32 M(+187.9%) | -$9.96 M(+73.6%) |
| Mar 2018 | - | -$1.85 M(+28.7%) | -$5.74 M(+28.6%) |
| Dec 2017 | -$4.46 M(+133.1%) | -$1.44 M(+5.6%) | -$4.46 M(+47.5%) |
| Sept 2017 | - | -$1.36 M(+24.1%) | -$3.02 M(+81.6%) |
| June 2017 | - | -$1.09 M(+92.1%) | -$1.67 M(+192.1%) |
| Mar 2017 | - | -$570.00 K | -$570.00 K |
| Dec 2016 | -$1.91 M | - | - |
FAQ
- What is Verrica Pharmaceuticals annual net profit?
- What is the all time high annual net income for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual net income year-on-year change?
- What is Verrica Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly net income year-on-year change?
- What is Verrica Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM net income year-on-year change?
What is Verrica Pharmaceuticals annual net profit?
The current annual net income of VRCA is -$67.00 M
What is the all time high annual net income for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual net profit is -$1.91 M
What is Verrica Pharmaceuticals annual net income year-on-year change?
Over the past year, VRCA annual net profit has changed by -$42.51 M (-173.59%)
What is Verrica Pharmaceuticals quarterly net profit?
The current quarterly net income of VRCA is -$22.86 M
What is the all time high quarterly net income for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly net profit is $83.00 K
What is Verrica Pharmaceuticals quarterly net income year-on-year change?
Over the past year, VRCA quarterly net profit has changed by +$1.94 M (+7.83%)
What is Verrica Pharmaceuticals TTM net profit?
The current TTM net income of VRCA is -$84.99 M
What is the all time high TTM net income for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM net profit is -$570.00 K
What is Verrica Pharmaceuticals TTM net income year-on-year change?
Over the past year, VRCA TTM net profit has changed by -$36.68 M (-75.92%)